Faruqi & Faruqi, LLP Investigates SelectQuote
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson is reaching out to investors who may have experienced losses in SelectQuote. He invites them to discuss their options directly.
If you bought or acquired securities from SelectQuote during the specified period and wish to know more about your legal rights, please contact Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
NEW YORK /PRNewswire/ — Faruqi & Faruqi, LLP, a prominent national securities law firm, is currently investigating possible claims against SelectQuote, Inc. ("SelectQuote" or the "Company") (NYSE: SLQT). They remind investors that there is a deadline to consider seeking the lead plaintiff position in an ongoing federal securities class action against the Company.
Understanding the Allegations Against SelectQuote
The firm has recovered substantial amounts for investors since its inception. As detailed in the complaint, the allegations assert that the Company and its executives made misleading statements and failed to disclose critical information, including:
- Directing Medicare beneficiaries toward the plans that offered higher compensation to SelectQuote, irrespective of their appropriateness or quality
- Not providing unbiased comparisons of Medicare Advantage insurance plans
- Receiving illegal kickbacks from certain insurers while restricting access to competing plans
- Non-compliance with various laws and agreements, making them vulnerable to regulatory actions
- Offering materially misleading statements about the Company’s operations and business prospects
Department of Justice Involvement
On May 1, 2025, the U.S. Department of Justice filed a complaint against SelectQuote under the False Claims Act. Allegations from the DOJ suggest that from 2016 until 2021, SelectQuote received substantial illegal kickbacks from health insurers for directing Medicare beneficiaries towards their plans. The DOJ indicated that SelectQuote’s claims of providing unbiased coverage comparisons were materially false, emphasizing that they consistently favored plans that were more profitable for the Company.
Impact on SelectQuote Stock
After this major announcement, SelectQuote's stock experienced a notable drop of 19.2%, closing at $2.56 per share amid unusual trading activity. This significant decline raised additional questions among investors about the overall health of the Company and its future.
What is the Role of a Lead Plaintiff?
The lead plaintiff in a securities class action is an investor who holds the largest financial interest in the sought relief and is typical of other class members. They guide the litigation on behalf of the group. Other investors have the right to either join this role or remain passive class members, and their recovery potential is not influenced by their choice in this matter.
Encouraging Whistleblowers and Information Providers
Faruqi & Faruqi, LLP strongly encourages anyone with knowledge regarding SelectQuote’s operations—this includes former employees, shareholders, and whistleblowers—to reach out for a discussion. Their insights may be critical in understanding the full situation surrounding the allegations.
For additional information on the SelectQuote situation and potential class action, you can visit www.faruqilaw.com/SLQT or reach out directly to Faruqi & Faruqi partner Josh Wilson.
Frequently Asked Questions
What is the main focus of the investigation by Faruqi & Faruqi?
The main focus is to investigate potential claims against SelectQuote regarding misleading statements and alleged illegal practices.
What are the specific allegations against SelectQuote?
SelectQuote is accused of directing Medicare beneficiaries to plans that paid them the most, failing to provide unbiased comparisons, and receiving kickbacks.
How can investors join the class action?
Investors who believe they have a stake in the outcome can contact the law firm or contribute as a lead plaintiff if they meet the criteria.
What was the stock price impact after the DOJ announcement?
The announcement from the DOJ led to the stock price of SelectQuote dropping significantly by 19.2% within a day.
How can individuals with information help?
Individuals with relevant knowledge or experiences relating to SelectQuote are encouraged to contact Faruqi & Faruqi, as their insights could be beneficial in the investigation.
